Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin
Fatima Naaz, Faiz Ahmad, Bilal Ahmad Lone, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103519-103519
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The importance of indole and azaindole scaffold in the development of antitumor agents
Yu Han, Wei Dong, Qunqun Guo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112506-112506
Closed Access | Times Cited: 130
1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships
Swarnagowri Nayak, Santosh L. Gaonkar, Ebraheem Abdu Musad, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 8, pp. 101284-101284
Open Access | Times Cited: 73
An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship
Ojasvi Gupta, Tathagata Pradhan, Gita Chawla
Journal of Molecular Structure (2022) Vol. 1274, pp. 134487-134487
Closed Access | Times Cited: 43
Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
Tarek A. Yousef, Abdulrahman G. Alhamzani, Mortaga M. Abou–Krisha, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13460-e13460
Open Access | Times Cited: 22
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12
Synthetic and Medicinal Perspective of 1,2,4‐Triazole as Anticancer Agents
Bhagyashri Rathod, Kapil Kumar
Chemistry & Biodiversity (2022) Vol. 19, Iss. 11
Closed Access | Times Cited: 21
New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: Design, synthesis, biological evaluation and molecular docking studies
Małgorzata Strzelecka, Benita Wiatrak, Paulina Jawień, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106758-106758
Open Access | Times Cited: 10
Indole Derivatives (2010–2020) As Versatile Tubulin Inhibitors: Synthesis and structure–activity Relationships
Fatima Naaz, Kumari Neha, Md Rafi Haider, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 20, pp. 1795-1828
Closed Access | Times Cited: 21
Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect
Tarek S. Ibrahim, Mohamed M. Hawwas, Azizah M. Malebari, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 802-818
Open Access | Times Cited: 20
Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked Bis-Indolyl Conjugates as Dual Inhibitors of Tankyrase and PI3K
Prasanna Anjaneyulu Yakkala, Samir Ranjan Panda, Syed Shafi, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7642-7642
Open Access | Times Cited: 14
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights
S. M. E. HASSAN, Alyaa Farid, Siva S. Panda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 922-922
Open Access | Times Cited: 2
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation
Ateyatallah Aljuhani, Mohamed S. Nafie, Nader R. Albujuq, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107827-107827
Closed Access | Times Cited: 2
1,3,4-Oxadiazole Containing Compounds As Therapeutic Targets For Cancer Therapy
Mohamed Jawed Ahsan
Mini-Reviews in Medicinal Chemistry (2021) Vol. 22, Iss. 1, pp. 164-197
Closed Access | Times Cited: 19
Multicomponent Domino Reaction for Concise Access to 2-Amino-Substituted 1,3,4 Oxadiazoles via Smiles Rearrangement
Prasanna Anjaneyulu Yakkala, Imran A. Khan, Srinivas Reddy Dannarm, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 17, pp. 12216-12223
Closed Access | Times Cited: 6
Current Advancement in the Oxadiazole-Based Scaffolds as Anticancer Agents
Garima Kapoor, Rubina Bhutani, Dharam Pal Pathak, et al.
Polycyclic aromatic compounds (2021) Vol. 42, Iss. 7, pp. 4183-4215
Closed Access | Times Cited: 14
Recent developments in the chemistry of 1H- and 4H-1,2,4-triazoles
Ashraf A. Abbas, Kamal M. Dawood
Advances in heterocyclic chemistry (2023), pp. 209-273
Closed Access | Times Cited: 5
1,2,3-Triazole Tethered Hybrid Capsaicinoids as Antiproliferative Agents Active against Lung Cancer Cells (A549)
Arif Khan, Fatima Naaz, Rafia Basit, et al.
ACS Omega (2022) Vol. 7, Iss. 36, pp. 32078-32100
Open Access | Times Cited: 9
Benzohydrazide as a good precursor for the synthesis of novel bioactive and anti-oxidant 2-phenyl-1,3,4-oxadiazol-aminoacid derivatives: Structural determination, biological and anti-oxidant activity
Khaled Briki, Talal Lahreche, Mouna Souad Abbassi, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 6, pp. 105767-105767
Open Access | Times Cited: 1
Synthesis, biological evaluation and mechanism study of a novel indole-pyridine chalcone derivative as antiproliferative agent against tumor cells through dual targeting tubulin and HK2
Mengzhu Zheng, Guangyuan Liu, Yawei Han, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117058-117058
Closed Access | Times Cited: 1
Synthesis, Molecular Docking and Evaluation of 1,3,4‐Oxadiazole‐Isobenzofuran Hybrids as Antimicrobial and Anticancer Agents
Swarnagowri Nayak, Santosh L. Gaonkar, Druti Hazra, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 5
Closed Access | Times Cited: 8
Design, Synthesis, Molecular Modelling and in Vitro Evaluation of Indolyl Ketohydrazide‐Hydrazone Analogs as Potential Pancreatic Lipase Inhibitors
Sakshi Jagetiya, Prashant S. Auti, Atish T. Paul
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 3
Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines
Parul Kaushik, Ravinder Kumar, Shiwani Khokhar, et al.
ChemistrySelect (2023) Vol. 8, Iss. 33
Open Access | Times Cited: 3
Synthesis, biological evaluation, and in silico studies of indole‐tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIα
Kashif Haider, Shivani Sharma, Yuba Raj Pokharel, et al.
Drug Development Research (2022) Vol. 83, Iss. 7, pp. 1555-1577
Closed Access | Times Cited: 5
Synthesis of new 1,3,4-oxadiazole-1,4-benzoxazinone hybrids as tubulin polymerization inhibiting anticancer agents and their in silico studies
Velaga Benarjee, B. Saritha, Hari Gangadhar K, et al.
Tetrahedron (2022) Vol. 124, pp. 132979-132979
Closed Access | Times Cited: 5
Synthesis of Some New Indole-1,3,4-Oxadiazole Hybrids as Tubulin Polymerization Inhibitors
Sunitha Boda, Satheesh Kumar Nukala, Ravinder Manchal
Russian Journal of Bioorganic Chemistry (2022) Vol. 48, Iss. S1, pp. S136-S143
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top